Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Asset Utilization Ratio (2020 - 2025)

Eton Pharmaceuticals' Asset Utilization Ratio history spans 7 years, with the latest figure at 0.66 for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio fell 5.92% to 0.66 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.66, a 5.92% decrease, with the full-year FY2025 number at 0.95, up 31.4% from a year prior.
  • Asset Utilization Ratio hit 0.66 in Q4 2025 for Eton Pharmaceuticals, up from 0.53 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for ETON hit a ceiling of 1.82 in Q1 2024 and a floor of 0.41 in Q1 2025.
  • Historically, Asset Utilization Ratio has averaged 0.88 across 5 years, with a median of 0.72 in 2022.
  • Biggest five-year swings in Asset Utilization Ratio: surged 5397.33% in 2021 and later plummeted 77.43% in 2025.
  • Tracing ETON's Asset Utilization Ratio over 5 years: stood at 0.81 in 2021, then rose by 0.52% to 0.81 in 2022, then surged by 110.81% to 1.71 in 2023, then tumbled by 59.28% to 0.7 in 2024, then decreased by 5.92% to 0.66 in 2025.
  • Business Quant data shows Asset Utilization Ratio for ETON at 0.66 in Q4 2025, 0.53 in Q3 2025, and 0.46 in Q2 2025.